Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
Status:
Terminated
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
This is a long-term open-label safety extension to the Phase 2a study of inhaled QCC374 in
adult patients with PAH. This study provides the patients who completed the QCC374X2201 study
with the option to continue receiving QCC374. The study will monitor the long-term safety,
tolerability and efficacy of QCC374 in patients with PAH.